News from NORD

New Guidelines Published for Diagnosis and Management of Cystathionine Beta-Synthase Deficiency


 

New guidelines for the diagnosis and management of cystathionine beta-synthase deficiency have been published in the Journal of Inherited Metabolic Disease . The HCU Network Australia recently hosted an online webinar featuring Andrew Morris MD, the primary author of the new guidelines.

Recommended Reading

NORD Urges Congress to Pass 21st Century Cures Act
Clinician Reviews
Nominate a Colleague for a NORD 2017 Rare Impact Award
Clinician Reviews
Certification in Rare Neuroimmunologic Disorders
Clinician Reviews
NORD Encourages Observing Rare Disease Day in Hospitals and Academic Centers
Clinician Reviews
January 13 Is Deadline for NORD Rare Impact Award Nominations
Clinician Reviews
Running Marathons to Advance Rare Disease Awareness and Diagnosis
Clinician Reviews
Major Three-Year Study of Undiagnosed Diseases Announced
Clinician Reviews
The Journey to an FTD Diagnosis Webinar Now Available
Clinician Reviews
Presentation Chronicles Pathway to Erdheim-Chester Diagnosis
Clinician Reviews
Speaking of NEC Podcast Series Now Has Companion Brochure
Clinician Reviews